Announcements Trials
Browse Landscape

Phase

Phase NA 19Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hematologic Neoplasms 2Sunburn 1Skin Neoplasms 1Pulmonary Disease, Chronic Obstructive 1Mucositis 1Lymphoma 1Head and Neck Neoplasms 1Fallopian Tube Neoplasms 1Colorectal Neoplasms 1Cigarette Smoking-Related Carcinoma 1Chronic Pain 1Carcinoma, Non-Small-Cell Lung 1Carcinoma in Situ 1Brenner Tumor 1Breast Neoplasms 1Arthralgia 1Anatomic Stage I Breast Cancer AJCC v8 1Abnormalities, Radiation-Induced 1

Interventions

Fluorouracil 131Leucovorin 127Oxaliplatin 93Bevacizumab 86Irinotecan 74Capecitabine 63Cetuximab 47Folfox protocol 32Panitumumab 18regorafenib 16trifluridine tipiracil drug combination 15Drug Therapy 14Chemotherapy, Adjuvant 13IFL protocol 10Floxuridine 10Radiotherapy 9Tegafur 7Neoadjuvant Therapy 7Levoleucovorin 7Laparoscopy 7Aspirin 7pembrolizumab 6Trifluridine 6Celecoxib 6atezolizumab 5XELOX 5Mitomycin 5Colonoscopy 5tipiracil 4sintilimab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Colorectal Neoplasms × Educational Status × Clear all
NCT01072851 2012-09-07

Tools for Improving Colorectal Cancer Screening Rates: Multimedia Versus Print

Trinity Health Of New England

Phase 3 Completed
920 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡